조영제 및 인젝터 시스템 시장 - 세계 및 지역별 분석 : 제품 및 국가별 분석 - 분석 및 예측(2022-2026년)

“Global Contrast Media Agent and Injector System Market to Reach $9,712.3 Million by 2026.”

Industry Overview

The global contrast media agent and injector system market was valued at $7,634.6 million in 2022 and is expected to reach $9,712.3 million by 2026, growing at a CAGR of 6.20% during the forecast period 2022-2026. The market is driven by factors such as the increasing prevalence of cancer and cardiovascular diseases leading to an upsurge in demand for imaging with contrast media agent and injector system and image-guided diagnostics.

Market Lifecycle Stage

The global contrast media agent and injector system market is developing. The global contrast media agent and injector system market has witnessed several collaborations among the market players. The collaborations are aimed at combining capabilities, expanding the customer base, and marketing, among others.

The opportunity for growth of the global contrast media agent and injector system market lies in continued research and development activities for manufacturing innovative contrast media agent and injector system. Many pharmaceutical companies are expanding their businesses and becoming more outsourcing-oriented.

Impact of COVID-19

The COVID-19 pandemic has significantly impacted the world's healthcare sector, especially the contrast media agent and injector system sector. The COVID-19 pandemic led to the rescheduling of non-essential diagnostic tests and treatment procedures in order to allocate more resources toward the management of COVID-19. The American College of Radiology postponed non-urgent outpatient visits in accordance with the guidelines put forth by the Centers for Disease Control and Preventio (CDC). According to a paper published in the Radiological Society of North America (RSNA) in April 2020, titled 'The Economic Impact of the COVID-19 Pandemic on Radiology Practices,' imaging volumes were affected with the greatest decline observed in outpatient settings, followed by emergency departments and inpatient settings.

The future impact of COVID-19 on the demand and supply across the global contrast media agent and injector system market depends on the abilities of stakeholders to withstand unforeseeable scenarios in the future. The intensity of impact due to COVID-19 in the future will depend on the current efforts being made by companies to equip their supply chains with the necessary components and processes to remain responsive.

Market Segmentation:

Segmentation 1: by Product

• Contrast Media Agents
• Injector Systems

The global contrast media agent and injector system market (by product) is expected to be dominated by the contrast media agents segment.

Segmentation: Contrast Media Agents (by Modality)

• X-Ray/CT Scan
• MRI
• Ultrasound

The global contrast media agent market (by modality) is expected to be dominated by the X-Ray/CT scan.

Segmentation: Contrast Media Agents (by Type of Media Agent)

• Iodine-Based Contrast Media Agent
• Gadolinium-Based Contrast Media Agent
• Barium-Based Contrast Media Agent
• Microbubble Contrast Media Agent
• Others

The global contrast media agent market (by type of media agent) is expected to be dominated by iodine-based contrast media agent.

Segmentation: Injector Systems (by Modality)

• CT Injector Systems
• MRI Injector Systems
• Cardiovascular/Angiography Injector Systems

The global contrast media injector system market (by modality) is expected to be dominated by CT injector systems.

Segmentation: Injector Systems (by Product)

• Injector
• Consumables and Accessories

The global contrast media injector system market (by product) is expected to be dominated by consumables and accessories.

Segmentation: Injector Systems (by Injector Type)

• Single-Head Injectors
• Dual-Head Injectors
• Syringeless Injectors

The global contrast media injector system market (by injector type) is expected to be dominated by single-head injectors.

Segmentation 2: by Region

• North America - U.S., Canada

• Europe - Germany, U.K., France, Italy, Spain, and Rest-of-Europe

• Asia-Pacific - China, Japan, India, Australia, and Rest-of-Asia-Pacific

• Rest-of-the-World

The global contrast media agent and injector system market (by region) is dominated by the North America region.

Recent Developments in Global Contrast Media Agent and Injector System Market

• In January 2023, Bayer AG received approval in Europe for its Ultravist-300, -370, an iodine-based contrast agent for contrast-enhanced mammography (CEM).

• In December 2022, Beijing Beilu Pharmaceutical Co. Ltd. expanded its business by establishing a wholly-owned subsidiary in Hong Kong.

• In April 2022, Beijing Beilu Pharmaceutical Co., Ltd.'s gadobutrol injection received the "Drug Registration Certificate" from the National Medial Production Administration (NMPA).

• In February 2023, Bracco Group partnered with Wellstar Health System. Through this partnership, the company conducted trials for its FDA-approved VUEWAY (gadopiclenol) injection, which is a contrast agent for use in MRI.

• In February 2023, Bracco Group acquired all the shares of Bracco-Eisai from Eisai. Furthermore, the company also changed the name of the company from Bracco-Eisai to Bracco Japan, Ltd.

• In July 2022, Fresenius Kabi, a subsidiary of Fresenius SE & Co. KGaA, launched its range of generic contrast media agents' generics in the U.S.

• In December 2022, General Electric Company partnered with ulrich GmbH & Co. KG. Through this partnership, the companies aimed to offer a branded multi-dose contrast media injector in the U.S.

Demand - Drivers and Limitations

The following are the drivers for the global contrast media agent and injector system market:

• Increasing prevalence of cancer and cardiovascular diseases leading to an upsurge in demand for imaging with contrast media agent and injector system
• Upsurge in demand for image-guided diagnostics
• Growing number of regulatory approvals

The market is expected to face some limitations as well due to the following challenges:

• Rising health concerns post usage of contrast media agents in the body

How can this report add value to an organization?

• Growth/Marketing Strategy: The global contrast media agent and injector system market has seen major development by key players operating in the market, such as business expansion, partnership, collaboration, and joint ventures.

• Competitive Strategy: The global contrast media agent and injector system market consists of various leading manufacturers, small-medium enterprises, and emerging startups. With the increasing demand for advanced devices, companies have the opportunity to expand their presence in the market through different strategic approaches. Some of the strategies followed by the leading contributors are the launch of new products, mergers and acquisitions, and regulatory and legal approvals.

Key Companies Profiled:

Table of Contents

1 Markets

• 1.1 Global Market Outlook
  • 1.1.1 Product Definition
  • 1.1.2 Inclusion and Exclusion Criteria
  • 1.1.3 Key Findings
• 1.2 Market Overview
• 1.3 Industry Outlook
  • 1.3.1 Regulatory and Legal Requirements and Framework
    • 1.3.1.1 Regulatory and Legal Requirements and Framework in the U.S.
    • 1.3.1.2 Regulatory and Legal Requirements and Framework in Europe
    • 1.3.1.3 Regulatory and Legal Requirements and Framework in Asia-Pacific
      • 1.3.1.3.1 China
      • 1.3.1.3.2 Japan
  • 1.3.2 Patent Analysis
    • 1.3.2.1 Patent Filing Trend (by Year)
    • 1.3.2.2 Patent Filing Trend (by Country)
  • 1.3.3 Key Trends
    • 1.3.3.1 Nanoparticle-Based Contrast Agents
    • 1.3.3.2 Development of Safer Contrast Media Agent
    • 1.3.3.3 Partnerships and Business Alliances among Players for Strong Foothold in Different Regions
• 1.4 Impact of COVID-19 on Contrast Media Agent and Injector System Market
  • 1.4.1 Pre-COVID-19 Impact
  • 1.4.2 During COVID-19 Impact
  • 1.4.3 Post-COVID-19 Impact
• 1.5 Market Dynamics
  • 1.5.1 Impact Analysis
  • 1.5.2 Market Drivers
    • 1.5.2.1 Increasing Prevalence of Cancer and Cardiovascular Diseases Leading to Upsurge Demand of Imaging with Contrast Media Agents and Injector System
    • 1.5.2.2 Upsurge in Demand for Image-Guided Diagnostics
    • 1.5.2.3 Growing Number of Regulatory Approvals
  • 1.5.3 Market Restraints
    • 1.5.3.1 Rising Health Concerns Post Usage of Contrast Media Agents in Body
  • 1.5.4 Market Opportunities
    • 1.5.4.1 IT Advances in Contrast Media Injectors

2 Product

• 2.1 Overview
• 2.2 Growth-Share Matrix
• 2.3 Contrast Media Agents
  • 2.3.1 Market Dynamics
  • 2.3.2 Market Size and Forecast
    • 2.3.2.1 By Modality
      • 2.3.2.1.1 X-Ray/CT Scan
      • 2.3.2.1.2 MRI
      • 2.3.2.1.3 Ultrasound
    • 2.3.2.2 By Type of Media Agent
      • 2.3.2.2.1 Iodine-Based Contrast Media Agent
      • 2.3.2.2.2 Gadolinium-Based Contrast Media Agent
      • 2.3.2.2.3 Barium-Based Contrast Media Agent
      • 2.3.2.2.4 Microbubble Contrast Media Agent
      • 2.3.2.2.5 Others
• 2.4 Injector Systems
  • 2.4.1 Market Dynamics
  • 2.4.2 Market Size and Forecast
    • 2.4.2.1 By Product
      • 2.4.2.1.1 Injector
      • 2.4.2.1.2 Consumables and Accessories
    • 2.4.2.2 By Modality
      • 2.4.2.2.1 CT Injector Systems
      • 2.4.2.2.2 MRI Injector Systems
      • 2.4.2.2.3 Cardiovascular/Angiography Injector Systems
    • 2.4.2.3 By Injector Type
      • 2.4.2.3.1 Single-Head Injectors
      • 2.4.2.3.2 Dual-Head Injectors
      • 2.4.2.3.3 Syringeless Injectors

3 Region

• 3.1 Overview
• 3.2 North America
  • 3.2.1 Key Findings
  • 3.2.2 Market Dynamics
  • 3.2.3 Impact Analysis
  • 3.2.4 Market Sizing and Forecast
    • 3.2.4.1 North America Contrast Media Agent and Injector System Market (by Product)
      • 3.2.4.1.1 North America Contrast Media Injector System Market (by Product)
    • 3.2.4.2 North America Contrast Media Agent and Injector System Market (by Country)
      • 3.2.4.2.1 U.S.
        • 3.2.4.2.1.1 Market Sizing and Forecast
        • 3.2.4.2.1.1.1 U.S. Contrast Media Agent and Injector System Market (by Product)
        • 3.2.4.2.1.1.1.1 U.S. Contrast Media Injector System Market (by Product)
      • 3.2.4.2.2 Canada
        • 3.2.4.2.2.1 Market Sizing and Forecast
        • 3.2.4.2.2.1.1 Canada Contrast Media Agent and Injector System Market (by Product)
        • 3.2.4.2.2.1.1.1 Canada Contrast Media Injector System Market (by Product)
• 3.3 Europe
  • 3.3.1 Key Findings
  • 3.3.2 Market Dynamics
    • 3.3.2.1 Impact Analysis
  • 3.3.3 Market Size and Forecast
    • 3.3.3.1 Europe Contrast Media Agent and Injector System Market (by Product)
      • 3.3.3.1.1 Europe Contrast Media Injector System Market (by Product)
    • 3.3.3.2 Europe Contrast Media Agent and Injector System Market (by Country)
      • 3.3.3.2.1 Germany
        • 3.3.3.2.1.1 Market Sizing and Forecast
        • 3.3.3.2.1.1.1 Germany Contrast Media Agent and Injector System Market (by Product)
        • 3.3.3.2.1.1.1.1 Germany Contrast Media Injector System Market (by Product)
      • 3.3.3.2.2 Italy
        • 3.3.3.2.2.1 Market Sizing and Forecast
        • 3.3.3.2.2.1.1 Italy Contrast Media Agent and Injector System Market (by Product)
        • 3.3.3.2.2.1.1.1 Italy Contrast Media Injector System Market (by Product)
      • 3.3.3.2.3 France
        • 3.3.3.2.3.1 Market Sizing and Forecast
        • 3.3.3.2.3.1.1 France Contrast Media Agent and Injector System Market (by Product)
        • 3.3.3.2.3.1.1.1 France Contrast Media Injector System Market (by Product)
      • 3.3.3.2.4 U.K.
        • 3.3.3.2.4.1 Market Sizing and Forecast
        • 3.3.3.2.4.1.1 U.K. Contrast Media Agent and Injector System Market (by Product)
        • 3.3.3.2.4.1.1.1 U.K. Contrast Media Injector System Market (by Product)
      • 3.3.3.2.5 Spain
        • 3.3.3.2.5.1 Market Sizing and Forecast
        • 3.3.3.2.5.1.1 Spain Contrast Media Agent and Injector System Market (by Product)
        • 3.3.3.2.5.1.1.1 Spain Contrast Media Injector System Market (by Product)
      • 3.3.3.2.6 Rest-of-Europe
        • 3.3.3.2.6.1 Market Sizing and Forecast
        • 3.3.3.2.6.1.1 Rest-of-Europe Contrast Media Agent and Injector System Market (by Product)
        • 3.3.3.2.6.1.1.1 Rest-of-Europe Contrast Media Injector System Market (by Product)
• 3.4 Asia-Pacific
  • 3.4.1 Key Findings
  • 3.4.2 Market Dynamics
    • 3.4.2.1 Impact Analysis
  • 3.4.3 Market Size and Forecast
    • 3.4.3.1 Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
      • 3.4.3.1.1 Asia-Pacific Contrast Media Injector System Market (by Product)
    • 3.4.3.2 Asia-Pacific Contrast Media Agent and Injector System Market (by Country)
      • 3.4.3.2.1 China
        • 3.4.3.2.1.1 Market Sizing and Forecast
        • 3.4.3.2.1.1.1 China Contrast Media Agent and Injector System Market (by Product)
        • 3.4.3.2.1.1.1.1 China Contrast Media Injector System Market (by Product)
      • 3.4.3.2.2 Japan
        • 3.4.3.2.2.1 Market Sizing and Forecast
        • 3.4.3.2.2.1.1 Japan Contrast Media Agent and Injector System Market (by Product)
        • 3.4.3.2.2.1.1.1 Japan Contrast Media Injector System Market (by Product)
      • 3.4.3.2.3 India
        • 3.4.3.2.3.1 Market Sizing and Forecast
        • 3.4.3.2.3.1.1 India Contrast Media Agent and Injector System Market (by Product)
        • 3.4.3.2.3.1.1.1 India Contrast Media Injector System Market (by Product)
      • 3.4.3.2.4 Australia
        • 3.4.3.2.4.1 Market Sizing and Forecast
        • 3.4.3.2.4.1.1 Australia Contrast Media Agent and Injector System Market (by Product)
        • 3.4.3.2.4.1.1.1 Australia Contrast Media Injector System Market (by Product)
      • 3.4.3.2.5 Rest-of-Asia-Pacific
        • 3.4.3.2.5.1 Market Sizing and Forecast
        • 3.4.3.2.5.1.1 Rest-of-Asia-Pacific Contrast Media Agent and Injector System Market (by Product)
        • 3.4.3.2.5.1.1.1 Rest-of-Asia-Pacific Contrast Media Injector System Market (by Product)
• 3.5 Rest-of-the-World
  • 3.5.1 Key Findings
  • 3.5.2 Market Dynamics
    • 3.5.2.1 Impact Analysis
  • 3.5.3 Market Size and Forecast
    • 3.5.3.1 Rest-of-the-World Contrast Media Agent and Injector System Market (by Product)
    • 3.5.3.2 Rest-of-the-World Contrast Media Injector System Market (by Product)

4 Markets - Competitive Benchmarking & Company Profiles

• 4.1 Competitive Benchmarking
  • 4.1.1 Key Strategies and Development
    • 4.1.1.1 Regulatory and Legal Activities
    • 4.1.1.2 Partnerships, Collaborations, and Business Expansions
    • 4.1.1.3 Mergers and Acquisitions
    • 4.1.1.4 New Offerings
  • 4.1.2 Market Share Analysis
    • 4.1.2.1 Market Share Analysis, by Contrast Media Agent Market
    • 4.1.2.2 Market Share Analysis, by Contrast Media Injector System Market
• 4.2 Contrast Media Ecosystem Active Players
• 4.3 Company Profiles
  • 4.3.1 Bayer AG
    • 4.3.1.1 Company Overview
    • 4.3.1.2 Role of Bayer AG in the Global Contrast Media Agent and Injector System Market
    • 4.3.1.3 Financials
    • 4.3.1.4 Recent Developments
    • 4.3.1.5 Analyst Perception
  • 4.3.2 Beijing Beilu Pharmaceutical Co. Ltd.
    • 4.3.2.1 Company Overview
    • 4.3.2.2 Role of Beijing Beilu Pharmaceutical Co. Ltd. in the Global Contrast Media Agent and Injector System Market
    • 4.3.2.3 Recent Developments
    • 4.3.2.4 Analyst Perception
  • 4.3.3 Bracco Group
    • 4.3.3.1 Company Overview
    • 4.3.3.2 Role of Bracco Group in the Global Contrast Media Agent and Injector System Market
    • 4.3.3.3 Recent Developments
    • 4.3.3.4 Analyst Perception
  • 4.3.4 Fresenius SE & Co. KGaA
    • 4.3.4.1 Company Overview
    • 4.3.4.2 Role of Fresenius SE & Co. KGaA in the Global Contrast Media Agent and Injector System Market
    • 4.3.4.3 Financials
    • 4.3.4.4 Recent Developments
    • 4.3.4.5 Analyst Perception
  • 4.3.5 FUJIFILM Holdings Corporation
    • 4.3.5.1 Company Overview
    • 4.3.5.2 Role of FUJIFILM Holdings Corporation in the Global Contrast Media Agent and Injector System Market
    • 4.3.5.3 Financials
    • 4.3.5.4 Analyst Perception
  • 4.3.6 General Electric Company
    • 4.3.6.1 Company Overview
    • 4.3.6.2 Role of General Electric Company in the Global Contrast Media Agent and Injector System Market
    • 4.3.6.3 Financials
    • 4.3.6.4 Recent Developments
    • 4.3.6.5 Analyst Perspective
  • 4.3.7 Guerbet
    • 4.3.7.1 Company Overview
    • 4.3.7.2 Role of Guerbet in the Global Contrast Media Agent and Injector System Market
    • 4.3.7.3 Financials
    • 4.3.7.4 Recent Developments
    • 4.3.7.5 Analyst Perception
  • 4.3.8 Jiangsu Hengrui Pharmaceutical Co., Ltd.
    • 4.3.8.1 Company Overview
    • 4.3.8.2 Role of Jiangsu Hengrui Pharmaceutical Co., Ltd. in the Global Contrast Media Agent and Injector System Market
    • 4.3.8.3 Recent Developments
    • 4.3.8.4 Analyst Perception
  • 4.3.9 Jodas Expoim Pvt. Ltd.
    • 4.3.9.1 Company Overview
    • 4.3.9.2 Role of Jodas Expoim Pvt. Ltd. in the Global Contrast Media Agent and Injector System Market
    • 4.3.9.3 Analyst Perception
  • 4.3.10 Lantheus Holdings, Inc.
    • 4.3.10.1 Company Overview
    • 4.3.10.2 Role of Lantheus Holdings, Inc. in the Global Contrast Media Agent and Injector System Market
    • 4.3.10.3 Financials
    • 4.3.10.4 Recent Developments
    • 4.3.10.5 Analyst Perspective
  • 4.3.11 Shenzen Seacrown Electromechanical Co., Ltd.
    • 4.3.11.1 Company Overview
    • 4.3.11.2 Role of Shenzen Seacrown Electromechanical Co., Ltd. in the Global Contrast Media Agent and Injector System Market
    • 4.3.11.3 Recent Developments
    • 4.3.11.4 Analyst Perception
  • 4.3.12 Sino Medical-Device Technology Co., Ltd.
    • 4.3.12.1 Company Overview
    • 4.3.12.2 Role of Sino Medical-Device Technology Co., Ltd. in the Global Contrast Media Agent and Injector System Market
    • 4.3.12.3 Analyst Perception
  • 4.3.13 ulrich GmbH & Co. KG
    • 4.3.13.1 Company Overview
    • 4.3.13.2 Role of ulrich GmbH & Co. KG in the Global Contrast Media Agent and Injector System Market
    • 4.3.13.3 Recent Developments
    • 4.3.13.4 Analyst Perception
  • 4.3.14 Unijules Life Sciences Ltd.
    • 4.3.14.1 Company Overview
    • 4.3.14.2 Role of Unijules Life Sciences Ltd. in the Global Contrast Media Agent and Injector System Market
    • 4.3.14.3 Analyst Perception